This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sirius XM, Radient Pharmaceuticals: Early Volume Plays

Stocks in this article: SIRI RPC

NEW YORK ( TheStreet) -- Sirius XM (SIRI) is among a handful of stocks trading near $5 poised to move on above-average volume Wednesday after the satellite radio provider offered subscriber metrics for its first quarter.

Sirius XM said it added 171,441 net subscribers in the first quarter of 2010, ending the three-month period with 18.94 million subscribers. That compares with a net loss of 404,422 subscribers in the first quarter of 2009. Deactivations fell by 11% compared to the first quarter of 2009, while gross additions rose 29%. Self-pay churn and conversation rate metrics also improved from the year-ago quarter.

Sirius XM, which said it will report full results in May, sports a 50-day average daily share volume of 160.97 million shares. More than 205 million shares changed hands on Tuesday after Janco Partners upgraded Sirius XM to buy from accumulate and raised its stock price target to $1.30 from 80 cents, citing operating leverage on a market rebound. Shares ended Tuesday's session at 96 cents.

>> Also See: Top Sirius ETFs

Elsewhere, Kulicke & Soffa (KLIC) shares surged by $1.36, or 17.3%, to $9.22 in Tuesday's after-market session after the semiconductor equipment maker reported second-quarter revenue of $153 million, which was above the $146.4 million consensus target, and guided third-quarter revenue above estimates. Kulicke & Soffa said it expects third-quarter revenue of $205 million, citing "unprecedented demand for both ball bonders and wedge bonders."

"This same strength in demand gives us visibility into the beginning of the September quarter and while it is too early to give guidance for that quarter, so far we are seeing a continuation of current customer demand patterns," Kulicke & Soffa said in the release. The 50-day average daily volume is 1.66 million.

Ameris Bancorp (ABCB) fell by 50 cents, or 5.2%, to $9.14 in Tuesday's late session after the company reported a first-quarter loss of 17 cents a share and said it has filed for a $12 million common stock offering. Ameris Bancorp added that it has commenced a separate $60 million offering it filed in March. The 50-day average daily volume for Ameris Bancorp is 36,000.

Radient Pharmaceuticals (RPC) is set to continue its recent slide after the company announced a dilutive financing deal late Tuesday. Radient announced the second closing of a 12% convertible promissory note and warrant financing for the sale of additional notes in the aggregate principal amount of $5.52 million. The warrants have a term of five years and are initially exercisable at 28 cents per share, the company said.

Radient shares closed Tuesday at $1.70 after falling 22.4% during the session ahead of the financing announcement. The three-month average daily volume for Radient is 2.2 million, according to Yahoo! Finance.

-- Written by Robert Holmes in Boston.

Check out all of Wednesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs